文献速递炎症性肠病消化道肿瘤与早癌

溃疡性结肠炎结直肠狭窄的发病率与危险因素:多中心研究

Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-01-22

这项多中心回顾性队列研究纳入439例溃疡性结肠炎(UC)患者,中位随访9.6年,结直肠狭窄发病率为3.6%,5年和10年累积概率分别为1%和2.3%。Montreal A3分型及使用类固醇是独立危险因素,而美沙拉秦治疗与较低风险相关。

要点

  • UC患者结直肠狭窄发病率3.6%,10年累积概率2.3%。
  • Montreal A3分型(年龄>40岁)和使用类固醇是独立危险因素。
  • 美沙拉秦治疗与较低狭窄风险相关。

核心结论

  • Montreal A3分型及使用类固醇的UC患者结直肠狭窄风险更高,使用美沙拉秦可降低风险。

研究设计与样本

  • 多中心回顾性队列研究,纳入2004年1月至2019年7月在Nancy大学医院和卢森堡中心医院随访的439例成人UC患者。

主要发现

  • 结直肠狭窄发病率为3.6%,5年累积概率为1%,10年累积概率为2.3%。
  • 狭窄诊断中位年龄为47.9岁(41.0; 63.0),从UC诊断到狭窄发生的中位时间为11.5年(5; 15.3)。
  • Montreal A3分型(年龄>40岁)(P = .008)和使用类固醇(HR = 4.1; 95% CI, 1.1-16.1)是狭窄的独立危险因素。
  • 接受美沙拉秦治疗的患者狭窄风险较低(HR = 0.3; 95% CI, 0.1-0.9)。
  • 6例狭窄患者发现异型增生(42.9%),其中5例发展为结直肠癌(33.3%)。

临床怎么用

  • 日常临床中应评估Montreal A3分型和使用类固醇这两项危险因素,以预防UC患者发生狭窄。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Ulcerative colitis (UC) is increasingly recognized as a progressive disease and patients with long-standing disease can develop colorectal stricture. Few data about its incidence in UC are available, while risk factors for colorectal strictures in UC remain to be determined. We assessed the incidence of and risk factors for developing colorectal strictures in a large UC population. METHODS: All adult patients followed at Nancy University hospital and at the centre hospitalier de Luxembourg for UC, between January 2004 and July 2019, were eligible for inclusion in this multicenter retrospective cohort study. RESULTS: A total of 439 patients with UC were included. Median follow-up duration was 9.6 years. Incidence of colorectal stricture was 3.6%. The cumulative probability of developing this complication was 1% at 5 years and 2.3% at 10 years. Median age at stricture diagnosis was 47.9 years (41.0; 63.0), and median time from UC diagnosis to onset of stricture was 11.5 years (5; 15.3). Montreal A3 classification (age > 40 years) (P = .008) and steroids use (HR = 4.1; 95% CI, 1.1-16.1) were independent risk factors for stricture, whereas mesalamine-treated patients carried a lower risk (HR = 0.3; 95% CI, 0.1-0.9). Dysplasia was found in 6 patients with strictures (42.9%) and among them 5 developed a colorectal cancer (33.3%). CONCLUSIONS: Patients with Montreal A3 classification and those exposed to steroids have a higher risk for strictures, while use of mesalamine lowers this risk. These factors should be assessed in daily clinical practice to prevent stricture occurrence in these patients.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Laurain PA, Guillo L, D'Amico F, et al. Incidence of and Risk Factors for Colorectal Strictures in Ulcerative Colitis: A Multicenter Study. Clin Gastroenterol Hepatol. 2021. PMID: 33493698. doi:10.1016/j.cgh.2021.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。